Breaking News
Get 45% Off 0
💰 With a 129% YTD gain in the bag, these are our AI’s top global picks for March
Read now

Stock Markets Analysis & Opinion

Contribute
Jason Sen
FTSE 100: No Sell Signal Whatsoever   By Jason Sen - Feb 15, 2022

DAX 40 was extremely volatile (which I still think is part of the process of building a bear trend) and breaking to the downside at last. EuroStoxx 50 March broke important support at 4060/50...

Devon Energy Stock To Consolidate By  - Feb 15, 2022 1

When we look at the Devon Energy Corporation (NYSE:DVN) price chart, we see its steady climb from the $50.50 range at the start of last week, well into the $54 price range where it stabilized and also...

Robert Lefter
S&P 500: Has The Rally Resumed? By Robert Lefter - Feb 15, 2022

An upside resolution remains most likely for the S&P 500. A fourth Elliott wave of intermediate degree is probably unfolding in the S&P 500. The black and red scenarios blueprint are the most...

Lance Roberts
Market Pullback Or Bear Market? By Lance Roberts - Feb 15, 2022 2

Such seems to be the question on everyone’s mind as of late, given the rough start to 2022 so far. There are undoubtedly many issues confronting even the most optimistic of investors...

Jea Yu
Upland Software Is A Low-Bar Play By Jea Yu  - Feb 15, 2022

Enterprise cloud workflow software solutions provider Upland Software (NASDAQ:UPLD) stock may have put in a bottom heading into its earnings. The enterprise software company already set the bar low...

Declan Fallon
Trading Action Tightens As Selling Stalls (A Little) By Declan Fallon - Feb 15, 2022 1

There wasn't a whole lot to Monday's action—which is probably a good thing.  There was no follow through lower; instead markets traded in a more neutral manner with a set of narrow range...

Michele Schneider
What To Do Next With No Clear Stock Market Direction By Michele Schneider - Feb 14, 2022 1

Currently, the market has been digesting last Friday’s big move and was not giving us any clear directional signs. After the major indices failed to clear key resistance levels last week...

Tim Knight
Moderna, Pfizer Get Tough Dose Of Medicine By Tim Knight - Feb 14, 2022 2

Moderna (NASDAQ:MRNA) has experienced a wipeout of nearly 75% in just six months. I’m sure the insiders dumped at just the right time and left the retail bag-holders wondering what just...

Guy S. Ortmann, CMT
Several Support Breaks But Trends Stay Neutral By Guy S. Ortmann, CMT - Feb 14, 2022

Data Remains NeutralAll the major equity indexes closed lower Friday with negative internals on the NYSE and NASDAQ as NYSE volumes dipped and NASDAQ volumes rose from the prior session. All closed at...

Continue with Apple
Continue with Google
or
Sign up with Email